{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,10]],"date-time":"2026-02-10T16:55:54Z","timestamp":1770742554729,"version":"3.49.0"},"reference-count":23,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,3,29]],"date-time":"2025-03-29T00:00:00Z","timestamp":1743206400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Farmacia Hospitalaria"],"published-print":{"date-parts":[[2025,7]]},"DOI":"10.1016\/j.farma.2025.03.019","type":"journal-article","created":{"date-parts":[[2025,5,10]],"date-time":"2025-05-10T15:27:56Z","timestamp":1746890876000},"page":"T235-T242","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["[Translated article] The need for prolonged antiviral use to prevent recurrences of herpes simplex virus ocular disease: A systematic review"],"prefix":"10.1016","volume":"49","author":[{"given":"Laura","family":"Ruiz Sifre","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sylvia","family":"Bort Mart\u00ed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vicente","family":"Ruiz Garc\u00eda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"\u00c1ngeles Ruth","family":"Bort Mart\u00ed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.farma.2025.03.019_bb0005","doi-asserted-by":"crossref","first-page":"1678","DOI":"10.1016\/j.ophtha.2017.05.012","article-title":"Update on the management of infectious keratitis","volume":"124","author":"Austin","year":"2017","journal-title":"Ophthalmology"},{"key":"10.1016\/j.farma.2025.03.019_bb0010","doi-asserted-by":"crossref","first-page":"185","DOI":"10.2147\/OPTH.S80475","article-title":"Herpes simplex keratitis: challenges in diagn\u00f3stico and clinical management","volume":"11","author":"Azher","year":"2017","journal-title":"Clin Ophthalmol"},{"key":"10.1016\/j.farma.2025.03.019_bb0015","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1007\/s11910-013-0414-8","article-title":"Update on herpes virus infections of the nervous system","volume":"13","author":"Steiner","year":"2013","journal-title":"Curr Neurol Neurosci Rep"},{"key":"10.1016\/j.farma.2025.03.019_bb0020","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1097\/ICU.0000000000000482","article-title":"Herpetic eye disease study: lessons learned","volume":"29","author":"Kalezic","year":"2018","journal-title":"Curr Opin Ophthalmol"},{"key":"10.1016\/j.farma.2025.03.019_bb0025","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1080\/09286586.2021.1962919","article-title":"Incidence of herpes simplex virus keratitis and other ocular disease: global review and estimates","volume":"29","author":"McCormick","year":"2022","journal-title":"Ophthalmic Epidemiol"},{"key":"10.1016\/j.farma.2025.03.019_bb0030","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1097\/ICU.0000000000000484","article-title":"Surgical management of herpetic keratitis","volume":"29","author":"Tuli","year":"2018","journal-title":"Curr Opin Ophthalmol"},{"key":"10.1016\/j.farma.2025.03.019_bb0035","unstructured":"White ML, Chodosh J. Herpes simplex virus keratitis: a treatment guideline; 2014. [Accessed 27 Oct 2024]. Available at: https:\/\/www.aao.org\/assets\/6564936e-9929-48b6-93cd-15872a1b388e\/635732518522630000\/hsv-keratitis-treatment-guideline-harvard-pdf."},{"key":"10.1016\/j.farma.2025.03.019_bb0040","unstructured":"Ruiz Garcia V, Bort Mart\u00ed A, Bort-Mart\u00ed S, Ruiz Sifre L. Antiviral agents for preventing recurrent herpes simplex keratitis. PROSPERO. International prospective register of systematic review; 2024. [Accessed 26 Oct 2024]. Available at: https:\/\/www.crd.york.ac.uk\/prospero\/display_record.php?RecordID=556228."},{"key":"10.1016\/j.farma.2025.03.019_bb0045","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1003583","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"18","author":"Page","year":"2021","journal-title":"PLoS Med"},{"key":"10.1016\/j.farma.2025.03.019_bb0050","series-title":"Cochrane handbook for systematic reviews of interventions version 6.5","article-title":"Chapter 8: Assessing risk of bias in a randomized trial [last updated October 2019]","author":"Higgins","year":"2024"},{"key":"10.1016\/j.farma.2025.03.019_bb0055","series-title":"Cochrane handbook for systematic reviews of interventions version 6.5","article-title":"Chapter 6: Choosing effect measures and computing estimates of effect [last updated August 2023]","author":"Higgins","year":"2024"},{"key":"10.1016\/j.farma.2025.03.019_bb0060","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1136\/bmj.39489.470347.AD","article-title":"GRADE: an emerging consensus on rating quality of evidence and strength of recommendations","volume":"336","author":"Guyatt","year":"2008","journal-title":"BMJ"},{"key":"10.1016\/j.farma.2025.03.019_bb0065","series-title":"Cochrane handbook for systematic reviews of interventions version 6.5","article-title":"Chapter 14: Completing \u2018Summary of findings\u2019 tables and grading the certainty of the evidence [last updated August 2023]","author":"Sch\u00fcnemann","year":"2024"},{"key":"10.1016\/j.farma.2025.03.019_bb0070","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1056\/NEJM199807303390503","article-title":"Acyclovir for the prevention of recurrent herpes simplex virus eye disease","volume":"339","author":"Wilhelmus","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1016\/j.farma.2025.03.019_bb0075","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/j.ajo.2007.06.001","article-title":"Efficacy of valacyclovir vs acyclovir for the prevention of recurrent herpes simplex virus eye disease: a pilot study","volume":"144","author":"Miserocchi","year":"2007","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.farma.2025.03.019_bb0080","doi-asserted-by":"crossref","first-page":"46","DOI":"10.4103\/0366-6999.147808","article-title":"Clinical efficacy of oral ganciclovir for prophylaxis and treatment of recurrent herpes simplex keratitis","volume":"128","author":"Wang","year":"2015","journal-title":"Chin Med J (Engl)"},{"key":"10.1016\/j.farma.2025.03.019_bb0085","first-page":"1569","article-title":"Acyclovir for the treatment and prevention of recurrent infectious herpes simplex keratitis","volume":"115","author":"Wu","year":"2002","journal-title":"Chin Med J (Engl)"},{"key":"10.1016\/j.farma.2025.03.019_bb0090","article-title":"Oral antivirals for preventing recurrent herpes simplex keratitis in people with corneal grafts","volume":"2016","author":"Bhatt","year":"2016","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.farma.2025.03.019_bb0095","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1076\/ocii.7.1.51.8113","article-title":"Efficacy of low-dose and long-term oral acyclovir therapy after penetrating keratoplasty for herpes simplex heratitis","volume":"7","author":"Akova","year":"1999","journal-title":"Ocul Immunol Inflamm"},{"key":"10.1016\/j.farma.2025.03.019_bb0100","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1097\/00003226-199405000-00007","article-title":"A prospective randomized trial of oral acyclovir after penetrating keratoplasty for herpes simplex keratitis","volume":"13","author":"Barney","year":"1994","journal-title":"Cornea"},{"key":"10.1016\/j.farma.2025.03.019_bb0105","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1007\/BF00154385","article-title":"Systemic acyclovir and penetrating keratoplasty for herpes simplex keratitis","volume":"80","author":"Foster","year":"1992","journal-title":"Doc Ophthalmol Adv Ophthalmol"},{"key":"10.1016\/j.farma.2025.03.019_bb0110","doi-asserted-by":"crossref","first-page":"1916","DOI":"10.1016\/S0161-6420(03)00798-X","article-title":"Effect of oral acyclovir after penetrating keratoplasty for herpetic keratitis: a placebo-controlled multicenter trial","volume":"110","author":"van Rooij","year":"2003","journal-title":"Ophthalmology"},{"key":"10.1016\/j.farma.2025.03.019_bb0115","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1007\/s00417-003-0724-7","article-title":"Synergistic antiherpetic effect of acyclovir and mycophenolate mofetil following keratoplasty in patients with herpetic eye disease: first results of a randomized pilot study","volume":"241","author":"Mayer","year":"2003","journal-title":"Graefes Arch Clin Exp Ophthalmol"}],"container-title":["Farmacia Hospitalaria"],"original-title":[],"language":"es","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1130634325000443?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1130634325000443?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,2,9]],"date-time":"2026-02-09T23:49:13Z","timestamp":1770680953000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1130634325000443"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7]]},"references-count":23,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,7]]}},"alternative-id":["S1130634325000443"],"URL":"https:\/\/doi.org\/10.1016\/j.farma.2025.03.019","relation":{},"ISSN":["1130-6343"],"issn-type":[{"value":"1130-6343","type":"print"}],"subject":[],"published":{"date-parts":[[2025,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"[Translated article] The need for prolonged antiviral use to prevent recurrences of herpes simplex virus ocular disease: A systematic review","name":"articletitle","label":"Article Title"},{"value":"Farmacia Hospitalaria","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.farma.2025.03.019","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.farma.2025.02.005","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Espa\u00f1a, S.L.U. on behalf of Sociedad Espa\u00f1ola de Farmacia Hospitalaria (S.E.F.H).","name":"copyright","label":"Copyright"}]}}